NUVB
Nuvation Bio Inc. (NUVB) reported net income of -$204.63M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$204.63M | +64.0% |
| FY 2024 | -$567.94M | -649.2% |
| FY 2023 | -$75.80M | +27.3% |
| FY 2022 | -$104.20M | -20.0% |
| FY 2021 | -$86.85M | -108.5% |
| FY 2020 | -$41.66M | - |
Nuvation Bio Inc. (NUVB) reported net income of -$204.63M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Nuvation Bio Inc.'s net income declined from -$41.66M to -$204.63M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.